| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21977e40c08969f3e950eb43ecafe0cb |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426 |
| filingDate |
2008-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_195e376dfac4b74028e556c2a4bde41b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_147bd09a69a6170fe0d1574d5c9b185e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c6fcc8a8090226e3e2aa73c38c308d5 |
| publicationDate |
2009-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-200927100-A |
| titleOfInvention |
Pharmaceutical composition for treating cataract |
| abstract |
The present invention provides an effective pharmaceutical composition for treating cataract. The said composition comprises VAP-1 (vascular adhesion protein-1) inhibitor, especially the compounds of formula (I), as the active ingredient. R1-NH-X-Y-Z (I) (where in, all symbols are defined as in the specification). |
| priorityDate |
2007-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |